AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Marketing.
In this role Gibb will be responsible for building and leading the sales organisation and strengthening the company's commercial presence.
Gibb has more than 20 years of global sales leadership experience. He has worked as VP of Sales and Marketing at Nortis Biosciences, VP of Global Sales at Araceli Biosciences, VP of Global Sales at Emulate, and held senior sales roles at Thermo Fisher Scientific and Becton Dickinson & Co.
Alif Saleh, AxoSim CEO, said: "We are excited to welcome Stuart as a key member of our team. He has an impressive track record in commercialising and scaling organ-on-a-chip platforms from zero to multi-million-dollar businesses."
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers